# Tissue Study of Bv8/PK-2 Inhibition in Human Cancer

> **NCT01656824** · — · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 20 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01656824
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656824, "Tissue Study of Bv8/PK-2 Inhibition in Human Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01656824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*